We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Analyzes Placentas at Birth to Accurately Detect Health Risks

By LabMedica International staff writers
Posted on 16 Dec 2024

The placenta is crucial to the health of both the pregnant individual and the baby during pregnancy, but it is often not examined thoroughly after birth, especially in areas with limited medical resources. More...

This oversight can prevent early detection of issues that could lead to complications, potentially missing opportunities for early intervention to improve outcomes for both mother and child. To address this, a new tool combining computer vision and artificial intelligence (AI) has been developed, which could help clinicians rapidly evaluate placental health at birth and improve neonatal and maternal care.

Researchers from Northwestern University (Evanston, IL, USA) and Penn State (University Park, PA, USA) have introduced a computer program named PlacentaVision. This tool analyzes a simple photograph of the placenta to identify abnormalities linked to infections and neonatal sepsis, a severe condition that affects millions of newborns globally. Early identification of infections through tools like PlacentaVision may allow clinicians to take swift action, such as administering antibiotics to the mother or baby and closely monitoring the newborn. According to the researchers, PlacentaVision is designed for use across diverse medical populations.

In their study, published in the journal Patterns, the researchers employed cross-modal contrastive learning, an AI technique that aligns and interprets the relationship between different types of data—visual (images) and textual (pathological reports). They compiled a large and varied dataset of placental images and associated pathological reports spanning 12 years, using this information to train the program to make predictions from new images. The team also developed various image modification strategies to simulate different conditions under which the photos were taken, helping to evaluate the model's robustness.

The outcome was PlacentaCLIP+, a powerful machine learning model that can accurately analyze placental images to detect health risks. The model was cross-nationally validated to ensure consistent performance across different populations. PlacentaVision is designed to be user-friendly, with potential applications through a smartphone app or integration into medical record systems, allowing doctors to receive immediate feedback post-delivery. Moving forward, the team plans to enhance the tool by incorporating additional placental features and clinical data, improving its predictive capabilities while also contributing to research on long-term health outcomes. They also aim to test the tool in various hospitals to ensure its functionality in different settings.

“Placenta is one of the most common specimens that we see in the lab,” said study co-author Dr. Jeffery Goldstein, director of perinatal pathology and an associate professor of pathology at Northwestern University Feinberg School of Medicine. “When the neonatal intensive care unit is treating a sick kid, even a few minutes can make a difference in medical decision making. With a diagnosis from these photographs, we can have an answer days earlier than we would in our normal process.”

“In low-resource areas — places where hospitals don’t have pathology labs or specialists — this tool could help doctors quickly spot issues like infections from a placenta,” added Yimu Pan, lead author on the study. “In well-equipped hospitals, the tool may eventually help doctors determine which placentas need further, detailed examination, making the process more efficient and ensuring the most important cases are prioritized.”


New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Clinical Chemistry System
P780
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.